中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2014年
13期
48-49,50
,共3页
王怡苹%秦侃%汪永宏%范鲁雁
王怡蘋%秦侃%汪永宏%範魯雁
왕이평%진간%왕영굉%범로안
介入手术%抗菌药物%合理用药
介入手術%抗菌藥物%閤理用藥
개입수술%항균약물%합리용약
intervention surgery%antibacterial drug%rational use
目的:调查介入手术患者围手术期预防使用抗菌药物情况,分析存在的问题。方法回顾性分析医院2012年1月至12月介入手术患者抗菌药物使用情况,剔除原有感染已使用抗菌药物的病例,同时实施干预管理。结果监测患者415例,预防使用抗菌药物27例,使用率6.51%;用药天数1~7 d,平均1.78 d;使用频率排名前5位的依次为头孢孟多、头孢西丁、青霉素、头孢哌酮他唑巴坦、头孢拉定。结论介入手术患者抗菌药物预防性使用情况比较合理,但仍存在用药时间过长、选取不正确等情况,需进一步提高临床医师对抗菌药物使用知识的了解,提高抗菌药物预防性应用的合理性。
目的:調查介入手術患者圍手術期預防使用抗菌藥物情況,分析存在的問題。方法迴顧性分析醫院2012年1月至12月介入手術患者抗菌藥物使用情況,剔除原有感染已使用抗菌藥物的病例,同時實施榦預管理。結果鑑測患者415例,預防使用抗菌藥物27例,使用率6.51%;用藥天數1~7 d,平均1.78 d;使用頻率排名前5位的依次為頭孢孟多、頭孢西丁、青黴素、頭孢哌酮他唑巴坦、頭孢拉定。結論介入手術患者抗菌藥物預防性使用情況比較閤理,但仍存在用藥時間過長、選取不正確等情況,需進一步提高臨床醫師對抗菌藥物使用知識的瞭解,提高抗菌藥物預防性應用的閤理性。
목적:조사개입수술환자위수술기예방사용항균약물정황,분석존재적문제。방법회고성분석의원2012년1월지12월개입수술환자항균약물사용정황,척제원유감염이사용항균약물적병례,동시실시간예관리。결과감측환자415례,예방사용항균약물27례,사용솔6.51%;용약천수1~7 d,평균1.78 d;사용빈솔배명전5위적의차위두포맹다、두포서정、청매소、두포고동타서파탄、두포랍정。결론개입수술환자항균약물예방성사용정황비교합리,단잉존재용약시간과장、선취불정학등정황,수진일보제고림상의사대항균약물사용지식적료해,제고항균약물예방성응용적합이성。
Objective To investigate the perioperative prophylactic antibacterial drug use in the patients with intervention surgery and to analyze the existing problems. Methods The retrospective analysis was performed to investigate the perioperative antibacterial drug use in the patients with intervention surgery from January to December 2012. The cases of original infection treated by the antibacterial drugs were excluded and at the same time the intervention management was implemented. Results A total of 415 cases were monitored, 27 cases used the prophylactic antibacterial drugs with the use rate of 6. 51%,the medication time ranged 1-7 d, average 1. 78 d. The top 5 of antibacterial drug use frequency in turn were cefamandole, cefoxitin, penicillin, cefoperazone tazobactam and cephradine. Conclusion The use of perioperative prophylactic antibacterial drug use in the patients undergoing intervention surgery is basically rea-sonable, but there are still some conditions such as too long time of antibacterial drug use and incorrect selection of antibacterial drugs, which needs to further increase the clinical doctors' understanding on the use knowledge of prophylactic antibacterial drugs for enhanc-ing the rationality of prophylactic antibacterial drug use.